Extracorporeal shock waves as curative therapy for varicose veins? by Angehrn, Fiorenzo et al.
© 2008 Angehrn et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article 
which permits unrestricted noncommercial use, provided the original work is properly cited.
Clinical Interventions in Aging 2008:3(1) 175–182 175
ORIGINAL RESEARCH
Extracorporeal shock waves as curative therapy 
for varicose veins?
Fiorenzo Angehrn1
Christoph Kuhn1
Ortrud Sonnabend2
Axel Voss3
1Klinik Piano, Biel, Switzerland; 
2Pathodiagnostics, Herisau, 
Switzerland; 3SwiTech Medical AG, 
Kreuzlingen, Switzerland
Correspondence: Fiorenzo Angehrn
Klinik Piano, Gottstattstrasse 24, 
CH-2504 Biel, Switzerland
Tel +41 32 344 40 40
Fax +1 41 32 344 40 42
Email angehrn@klinikpiano.ch
Abstract: In this prospective design study the effects of low-energy partially focused 
extracorporeal generated shock waves (ESW) onto a subcutaneous located varicose vein – left 
vena saphena magna (VSM) – are investigated. The treatment consisted of 4 ESW applications 
within 21 days. The varicose VSM of both sides were removed by surgery, and samples analyzed 
comparing the treated and untreated by means of histopathology. No damage to the treated 
varicose vein in particular and no mechanical destruction to the varicose vein’s wall could be 
demonstrated. However, an induction of neo-collagenogenesis was observed. The thickness of the 
varicose vein’s wall increased. Optimization of critical application parameters by investigating 
a larger number of patients may turn ESW into a non-invasive curative varicose treatment.
Keywords: curative therapy, extra-cellular matrix (ECM), histopathologic changes of varicose 
veins, extracorporeal shock wave (ESW), progenitor cells
Introduction
Normal veins and varicose veins
From the lumen to the periphery of a normal vein one can recognize (Somers and 
Knaapen 2006):
  (i)  tunica intima: endothelium, a thin layer of smooth muscle cells (SMC) embedded 
in sub-endothelial connective tissue; the elastic ﬁ  bers tend to be parallel to the 
inner elastic lamina.
 (ii)  tunica media: inconspicuous inner layer of longitudinally oriented SMC, and 
a more prominent outer layer of circular oriented SMC, both embedded in an 
extracellular matrix (collagen); the elastin pattern formation around individual 
SMC indicates spiral connection of contractile-elastic units of vein wall; the 
thickness varies from the proximal to the distal region of the vein according to 
the number of circumferentially orientated SMC whorls; the outer elastic lamina 
demarcates the end of the tunica media.
(iii)  tunica adventitia: clusters of longitudinally oriented SMC, ﬁ  broblasts, capillar-
ies (vasa vasorum), bundles of collagen and elastic ﬁ  bers interwoven with each 
other to provide strength and resilience.
Varicose veins are found mainly at the lower extremities of the body, especially 
on the back of the calf or on the inside of the thighs and may involve saphenous 
veins, saphenous tributaries, or non-saphenous superﬁ  cial leg veins and perforators. 
Varicose veins are usually tortuous, but tubular saphenous veins with demonstrated 
reﬂ  ux may be classiﬁ  ed as varicose veins. The prevalence of varicose veins is deﬁ  nitely 
underestimated and affects up to 40% of men and up to 51% of women (Somers and 
Knaapen 2006).
The vein wall distensibility is controlled by collagen, elastin, and SMC, the content 
of collagen is 47% and elastin is 7% of the normal venous vessel wall (Somers and Clinical Interventions in Aging 2008:3(1) 176
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Knaapen 2006). Dilatation and distensibility of a varicose 
vein is due to a deﬁ  ciency in smooth muscle cells (these lose 
normal fusiform shape and gain marked phagocytic activity) 
and elastic ﬁ  bers, and also to a disorganization of the elastin/
collagen lattice network and a disproportionate increase in 
amorphous and ﬁ  brous tissue (Wali et al 2003). The lesions 
are not concentric (hypertrophy with atrophic areas), which 
explains the bulgings of varicosis.
The amount of collagen increases with senescence, a 
phenomenon known as phlebosclerosis (Leu et al 1991). 
Aging is deﬁ  ned as a genetic physiological process associated 
with morphological and functional changes in cellular and 
extra-cellular components (Drubaix et al 1998) aggravated by 
injury throughout life, resulting in a progressive imbalance 
of the control regulatory systems of the organism, including 
hormonal, auto-crine, neuro-endocrine, and immune homeo-
static mechanisms (King 1988). According to this deﬁ  nition 
varicose veins could then be regarded more as an aging of 
the veins than as a disease.
Treatment options of varicose veins
Treatments of varicose veins have the common aim reducing 
venous recirculation and correcting the venous blood-ﬂ  ow. 
Table 1 shows the principal therapies.
In all these forms of therapy even fundamental mea-
sures are valued differently (eg, the necessity of cross-
ectomy). In addition there is little known about the reason 
why long-term therapy results are essentially disappoint-
ing (predisposition, technical problems, delayed interven-
tion, neoangiogenesis). Minkiewicz stated in 1862: “The 
plain number of surgically and therapeutically practices 
being proposed as healing methods against specific dis-
eases is evidence that (i) either these practices are still 
not enough explored or (ii) that the real healing method 
is yet to be found. This analysis is very true for varicose 
veins and their usual surgery methods” (Minkiewicz 
1862, 1869).
Extracorporeal shock wave therapy 
(ESWT)
The extracorporeal generated shock wave therapy (ESWT) 
is the gold standard worldwide to treat urolithiasis. This 
method is used now for many other indications, eg, of 
musculoskeletal diseases (such as calcaneal spur, tennis-
elbow, golf-arm, lime-shoulder, patella-tip syndrome, 
ectopic calciﬁ  cation, and pseudarthrosis) (Siebert and Buch 
1997; Wang et al 2006) and of soft-tissue diseases (such 
as cellulite and venous ulcus cruris) as well as burns, and 
arterial and diabetic ulcus (Siems et al 2005; Sparsa et al 
2005; Schaden et al 2006). The general positive response 
from our patients to ESWT, the observation of tissue 
strengthening and “regeneration” (Angehrn et al 2007; 
Kuhn et al 2007), as well as new methods and new results 
on effects, led us to investigate the effects of ESWT on 
varicose veins.
Posing the problem
What are the effects of ESWT on the varicose vein? No 
experimental or clinical data on this issue are available. Can 
this technique achieve a “restitutio ad integrum” of varicose 
veins? No healing procedures are known for varicose veins. 
The following hypotheses were tested (using adjustments of 
ESW device parameters as deﬁ  ned in Table 4) on changes 
in the varicose vena saphena magna (VSM):
•  ESWT does not cause tissue injury.
•   ESWT does not cause changes to the luminal wall of veins 
that would lead to thrombosis or occlusion of the vein.
•  ESWT strengthens veins and stabilizes vein walls.
•  ESWT improves venous function.
The physics of ESW
Shockwaves are acoustic pressure pulses of some micro-
seconds duration that transmit energy from the place of 
generation, such as lightning strikes, to distant areas, where 
they are audibly perceived as loud thunder (as in lightening 
strikes). Shock waves (Figure 1) are presented by a single, 
positive pressure pulse arising from ambient pressure within 
nanoseconds to large amplitude up to more than 100 MPa 
followed by an exponential descent. Subsequently there is a 
comparatively small tensile wave component below ambi-
ent pressure with negative pressure up to 20% of the value 
reached by the positive pressure peak and of comparable long 
duration (2000 nanosec) (Gerdersmeyer et al 2002; Urhahne 
2005; Wess 2006).
The bio-medical effects of ESW (Neuland et al 2004) 
depend on the form and amplitude of the shock wave at the 
Table 1 Diverse measures to relieve from venous disease, no 
curative therapy
•   Relieve venous load by elevation and by compression (compression 
socks, elastic bandage)
•   Eliminating veins by surgery (crossectomy, stripping, phlebectomy by 
Muller, Trivex-process)
•   Closing the lumen of veins (sclerotherapy, endovenous LASER and 
endovenous radio-frequency therapy)
•   Correcting and preserving veins (external valvuloplasty, CHIVA-
method)Clinical Interventions in Aging 2008:3(1) 177
Extracoporeal shock waves for varicose veins
place of interest within the tissue. The pressure-time curve 
at a speciﬁ  c location in the tissue is mainly dependent (i) on 
how the shock wave is generated (device-speciﬁ  c parameters) 
and (ii) on the path through the tissue: effects that make 
the pressure pulse even steeper due to non-linearities in the 
propagation medium as well as phenomena such as refraction 
and diffraction at acoustic interfaces have to be taken into 
consideration. Besides changing the energy ﬂ  ow density and 
the frequency of shock waves, their focus can be adjusted 
to generate defocused, partially focused, or focused shock 
waves. Defocused shock waves distribute radially into the 
tissue, where the intensity diminishes with the third potency 
of distance covered (1/r3). A focused shock wave, on the other 
hand, is generated by an elliptic acoustic mirror where again 
each component shock wave distributes radially into the tis-
sue, but the sum of all component shock waves add up to a 
speciﬁ  c focus within the tissue, where the intensity peaks.
The biological effects of ESW
Shock waves traveling through the human body lose 
mechanical energy, especially at the rear interface between 
tissues with different acoustical impedance (Table 2). The 
fragmentation of a kidney stone is a good example of how 
the shock wave hits the interface kidney/kidney-stone (Hoff 
and Behrend 1973).
Cavitation bubbles are generated within the propagation 
medium by the tensile component of the shock wave (Hae-
ussler and Kiefer 1971; Wolfrum et al 2003). These cavita-
tion bubbles collapse after passage of the shock wave, and 
transform into micro-jets which subsequently may add up to 
large jet-streams with velocities as high as 800 m/sec.
It has been observed that ESWT applied to bone marrow 
promotes the generation of progenitor cells (Wang et al 2002; 
Schmidt et al 2007; Yang et al 2007). Progenitor cells have 
a great regeneration capacity and, in contrast to stem cells, 
their future tissue function is predetermined. This behavior 
is not at all a drawback but is ideal for the regeneration of the 
speciﬁ  c tissue of an organ. If activation of progenitor cells 
is conjectured to be a general effect of low energy, partially 
focused ESW, it may also achieve a curative “restitutio ad 
integrum” in case of varicose veins.
On the other hand a higher energy ﬂ  ow density may 
achieve total disintegration and thus a destruction of a 
strongly degenerated vein. Future research on treating 
varicose veins with ESW will show if a similar reaction takes 
place as for the sclero-therapy, radio-wave-therapy or as for 
the endoluminal laser-therapy. If so, ESW could be applied 
for strongly advanced varicose veins. The great advantage 
of such a method is its total non-invasiveness and the fact 
no blood vessel needs to be opened.
Case study: methods, materials, 
and human resource
Patient
A woman aged 50 had a symptomatic varicose equally on both 
sides (CEAP-classiﬁ  cation: C2EpAs2As3As5Ap17Ap18Pr) 
and surgery was indicated. She gave informed consent to 
be treated for the cellulite with ESWT on the left thigh 
at deﬁ  ned time-intervals 4 times (Table 3) before venous 
surgery. No other treatment (such as medical stockings, 
phlebotropic drugs) was carried out during the study period. 
Table 2 Acoustical impedance values of different human body 
tissues
Substance tissue  Impedance [103 kg/s m2]
  (lower and upper limits)
Air 429
Water 1480
Fat 138
Lung 260  ——  460
Brain 1600
Blood 1620
Kidney 1630
Liver 1650
Muscle 1650  ——  1740
Bone  3200 —— 7400
Kidney-stone 5600  ——  14400
Figure 1 Pressure-time curve of a shock wave.
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Table 3 ESW application regime
Start  1st  ESW application  1\4 length of VSM
7th day  2nd  ESW application  1\2 length of VSM
14th day  3rd  ESW application  3\4 length of VSM
21st day  4th  ESW application  Full length of VSMClinical Interventions in Aging 2008:3(1) 178
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The left (sections with 1, 2, 3, and 4 ESW treatments) 
and right (no treatment) VSM were removed as non-
traumatically as possible by non-invaginated stripping 
(which includes crossectomy, inserting a ﬁ  lament into 
the lumen of the VSM, and extracting the vein by cutting 
with a hemispherical blade which was ﬁ  xed on top of the 
ﬁ  lament). They were then ﬁ  xed in 4% buffered formalin 
and processed for histology by slicing uniformly the whole 
material and analyzing each slide.
ESW device
The shock waves were produced by electro-hydraulic means 
with the device ActiVitor-Derma®, the probe ActiVitor Probe 
D0 (SwiTech Medical AG), with the adjustments shown in 
Table 4.
LCCT device
Liquid-crystal-contact-thermography (LCCT) can measure 
minor differences in skin temperature (Hoffmann et al 1989). 
An increase in the micro-perfusion of the surrounding tis-
sue treated by ESW can be made visible on the skin by this 
device (Figure 2).
Photoplethysmography (PPG)
Relative changes in blood volume in the dermis of the limb 
can be determined by measuring with a photo-sensor the 
backscatter of light emitted from a diode. A PPG probe is 
placed on the foot with maneuvers to “empty” the foot by 
calf muscle contraction. The “venous reﬁ  ll time” is the time 
required to return to 90% of the baseline after cessation of 
calf contraction. A venous reﬁ  ll time 18 seconds indicates 
chronic vein insufﬁ  ciency, a venous reﬁ  ll time 25 seconds 
suggests normal venous ﬁ  lling.
Duplex sonography
This is part of the routine medical examination.
Results
Dynamic photoplethysmography of the VSM yielded an improve-
ment in the venous ﬁ  lling time (from before to after treatment) 
from 22 to 29 sec (left side) and from 18 to 19 sec (right side). 
This result supports the hypothesis of a functional improvement 
by low-energy partially focused ESW. Additional support is given 
by color-coded Duplex-sonography measuring a decrease of the 
VSM’s minimal diameter 1 cm below the cross (junction VSM 
into v. femoralis communis). This decrease was also visible in 
the histological sample. However, reﬂ  ux could not be corrected. 
This single value supports the hypothesis of a restitutio of the 
vein’s wall by low-energy partially focused ESW.
Histopathological results provide evidence that low-
energy partially focused ESW increases the scaffolding fabric 
Table 4 Application parameters for ESW treatment of medial 
thigh
Focus Partially  focused
6 dB (= 50%) isobar 
length (z)  16 mm
diameter (∅, x, y)  23.5 mm
penetration depth  7–8 mm
Pressure rising-time  10–15 nsec
Shock-wave duration  1–2 µsec
Positive pressure peak  21 MPa
Negative pressure peak  1 MPa
Energy ﬂ  ow density per pulse  0.027 mJ/mm2
Frequency 4  Hz
Number of pulses  40/cm2
Treated area  4 cm × 50 cm
Total duration  33 min
No
ESW
application
Immediately
after third
ESW
application
Figure 2 Liquid-crystal-contact-thermography (LCCT) model RW27ST (with colors 
corresponding to temperature steps of 0.7 ºC) of left proximal medial thigh skin taken 
before (top) and after (bottom) low energy partially focused ESW treatment along 
trace of vena saphena magna (VSM) showing hyperthermia for several days, implying 
an increased micro-perfusion of the underlying tissue.Clinical Interventions in Aging 2008:3(1) 179
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of the varicose vein’s wall, particularly collagen. The amount 
of elastic ﬁ  bers and smooth muscle cells probably increased 
as well. The thickness of the varicose vein’s wall increased 
(Figure 3). The vein’s endothel is seen to be damaged because 
of stripping, whereas the endothel of the vasa vasorum are 
seen to be undamaged by ESW.
Discussion
The degenerative changes of varicose veins correlate with 
those of the patient’s skin (Sansilvestri-Morel 2007) and the 
tissues of other organs (Forster et al 2006). This observation 
has led to the concept of the “impairment of the connective 
tissue” and to the interpretation that varicose veins can be seen 
as a consequence of a hereditary impairment of the connective 
tissue (Tsukanov and Tsukanov 2004). This hereditary aspect 
is supported by the evidence of FOXC2 gene-mutation of 
patients with insufﬁ  ciency of the vein’s valves (Mellor et al 
2007) and the changes in the expression of tenascin-C of the 
varicose patient in comparison to patients with normal veins 
(Kirsch et al 1999). Research on the extra-cellular matrix of 
varicose veins by performing immuno-histochemistry has 
shown that the primary cause of varicose is an increase of 
expression of metalloproteinase and a decrease of elastic 
ﬁ  bers and their fragmentation (Michliels et al 2001; Somers 
and Knaapen 2006; Jeanneret et al 2007). The insufﬁ  ciency of 
the vein’s valves is then seen as the consequence of the impair-
ment of the vein’s wall. Because the structure of skin’s col-
lagen is improved by ESW application (Angehrn et al 2007; 
Kuhn et al 2007), we considered that similar positive results 
can be achieved by application of ESW on varicose veins.
Reported effects of ESWT at the cellular level are diverse. 
Light microscopy or electron microscopy show either no 
changes within cells, or a complete destruction of cells. Pub-
lished results show changes in the cell’s membrane structure 
(Seidl et al 1994), edema of the cell, increase of vacuoles 
within the cytoplasm, dilatation of the endoplasmatic reticu-
lum, peri-nuclear cysternae, enlargement or destruction of 
mitochondria, or even lethal damage of the cell (Seidl et al 
1994). On the human endothel there is evidence of changes 
in the permeability and even dissection of the endothel’s cells 
(Seidl et al 1994). ESW with energy ﬂ  ow density of more 
of than 0.3 mJ/mm2 was found to damage vascular walls 
(Steinbach et al 1993; Verna et al 2006).
Some evidence of the effects of ESWT on the molecular 
level is known (positive effect of ESW on the proliferation 
of endothelial progenitor cells [Aicher et al 2006] or the 
increased proliferation of osteoprogenitor cells [Wang et al 
2002]). These experiments with cells from connective tissue 
and supporting tissue showed in ﬁ  broblasts a decrease in the 
survival rate proportional to the energy ﬂ  ow density. After a 
few days there was an increase in the proliferation rate of bone 
cells (osteoplasts), a sign of regeneration starting. Altogether 
the clinical studies show an osteoneogenetic effect of ESW 
application. Correct application of ESW causes no clinically 
relevant or ongoing damage.
Unwanted side effects on the large venous vessels after 
ESWT for ureterolithiasis are rare, but these incidences 
cannot be taken for comparison because of the usage of 
diverse energy ﬂ  ow densities (deep thrombosis of the femoral 
vein in case of activated protein C [APC or factor V Leiden] 
resistance [Brodmann et al 1998], thrombosis of the iliacal 
vein [Desmet et al 1989], thrombosis of the portal vein in the 
case of hypoﬁ  brinolysis [Abecassis et al 1991]).
The significant result of this study is that in vivo 
application of low-energy partially focused ESW with 
an energy ﬂ  ow density of 0.027 mJ/mm2 increased the 
scaffolding fabric of the varicose vein’s wall, particularly 
collagen, and probably also the elastic ﬁ  bers and smooth 
muscle cells.
Conclusion
Since the apparently encouraging results on neocollageno-
genesis and possibly neoelastino-genesis and neogenesis of 
smooth muscle cells were obtained from a single case, their 
clinical relevance cannot be deduced conclusively. However, 
the results suggest that further research with a larger group 
of patients is essential and worthwhile to show:
 (i)  the adequate dosage, frequency, and focus attributes of 
ESW application to generate selectively constituents for 
recovery of the varicose vein’s wall and thereby to open 
the way for a proper curative and non-invasive therapy 
for varicose vein (our conception);
(ii) that  ESW application leads to even more inclusion 
of collagen as in terms of phlebosclerosis with an 
adequate dosage, frequency, and focus attributes to 
obstruct varicose veins safely and in a controlled way. 
In doing so, ESW would open a way to therapy that is 
as effective as other therapies such as sclero-therapy, 
radiowave-therapy, or endoluminar laser-therapy, but 
is completely non-invasive.
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